Could a palm vitamin e supplement help repair Alcohol-Damaged livers?
NCT ID NCT07466485
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This phase II trial tests whether a palm-derived form of vitamin E (tocotrienol) can improve liver health in adults with alcoholic fatty liver disease. 26 participants will take either the supplement or a placebo for six months, with regular blood tests and liver scans to track changes. The goal is to see if this natural supplement can reduce liver damage and support better liver function.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- palm tocotrienol (a form of vitamin E)
- What this could lead to
- If it works, this could point toward a natural supplement to help manage alcoholic fatty liver disease and improve liver function.
- What could go wrong
- This is a small, early-phase trial with only 26 participants. Results may not apply to everyone, and the supplement may not show significant benefit over placebo.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALCOHOLIC FATTY LIVER DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hospital Canselor Tuanku Muhriz Universiti Kebangsaan Malaysia, Jalan Yaacob Latif, Bandar Tun Razak
Cheras, Kuala Lumpur, 56000, Malaysia
More trials for these conditions
Other studies related to the condition(s) this trial covers.